Cargando…
The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis
BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982199/ https://www.ncbi.nlm.nih.gov/pubmed/33725984 http://dx.doi.org/10.1097/MD.0000000000025080 |
_version_ | 1783667669480767488 |
---|---|
author | Zhang, Shuzhen Wang, Lei Zhang, Jing An, Wei Jia, Li |
author_facet | Zhang, Shuzhen Wang, Lei Zhang, Jing An, Wei Jia, Li |
author_sort | Zhang, Shuzhen |
collection | PubMed |
description | BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence. Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. METHODS: CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. The retrieval time was from the establishment of the database to February 2021. Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.3 software. RESULTS: This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions. CONCLUSION: This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/AZU47 |
format | Online Article Text |
id | pubmed-7982199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-79821992021-03-23 The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis Zhang, Shuzhen Wang, Lei Zhang, Jing An, Wei Jia, Li Medicine (Baltimore) 3800 BACKGROUND: Endometriosis (EMS) is one of the common diseases in women, which seriously affects the quality of life of women. Leuprorelin acetate can control the development of EMS, but long-term use can cause perimenopausal symptoms in women. Clinical studies have shown that Kuntai capsule combined with leuprorelin acetate is effective in the treatment of EMS, which can relieve perimenopausal symptoms, but it lacks of evidence-based medical evidence. Therefore, this study aims to systematically evaluate the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. METHODS: CNKI, VIP, Wanfang, Chinese Biomedical Literature Database, PubMed, The Cochrance Library, Embase, Web of Science, and other databases were searched by computer to collect randomized controlled trials of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. The retrieval time was from the establishment of the database to February 2021. Two researchers screened the literatures and extracted the data and meta-analysis was performed using RevMan 5.3 software. RESULTS: This study evaluated the efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS by clinical effective rate, serum sex hormone levels estradiol, follicle-stimulating hormone, luteinizing hormone, visual analogue scale, Kupperman score and incidence of adverse reactions. CONCLUSION: This study will provide reliable evidence-based evidence for the clinical application of Kuntai capsule combined with leuprorelin acetate in the treatment of EMS. ETHICS AND DISSEMINATION: Private information from individuals will not be published. This systematic review also does not involve endangering participant rights. Ethical approval will not be required. The results may be published in a peer-reviewed journal or disseminated at relevant conferences. OSF REGISTRATION NUMBER: DOI 10.17605/OSF.IO/AZU47 Lippincott Williams & Wilkins 2021-03-19 /pmc/articles/PMC7982199/ /pubmed/33725984 http://dx.doi.org/10.1097/MD.0000000000025080 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Zhang, Shuzhen Wang, Lei Zhang, Jing An, Wei Jia, Li The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title | The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title_full | The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title_fullStr | The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title_full_unstemmed | The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title_short | The efficacy and safety of Kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: A protocol for systematic review and meta-analysis |
title_sort | efficacy and safety of kuntai capsule combined with leuprorelin acetate in the treatment of endometriosis: a protocol for systematic review and meta-analysis |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982199/ https://www.ncbi.nlm.nih.gov/pubmed/33725984 http://dx.doi.org/10.1097/MD.0000000000025080 |
work_keys_str_mv | AT zhangshuzhen theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT wanglei theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT zhangjing theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT anwei theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT jiali theefficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT zhangshuzhen efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT wanglei efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT zhangjing efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT anwei efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis AT jiali efficacyandsafetyofkuntaicapsulecombinedwithleuprorelinacetateinthetreatmentofendometriosisaprotocolforsystematicreviewandmetaanalysis |